Approximately 10–15% of patients clinically diagnosed with TSC do not have detectable TSC1/2 germline mutations using conventional exon sequencing methods (3), possibly due to functional germline mutations in intronic regions not covered by NGS probes or mosaic mutations (4, 5). This evidence concerns the gene TSC1 and tuberous sclerosis.